Dr. Mike Mazanetz joined Pangea and its operating companies as Senior Computational Chemist Expert contributing to and advising on medicinal and computational chemistry efforts and early drug discovery.
Mike is founder and managing director of NovaData Solutions based in Oxfordshire, UK. He has more than 20 years of experience in the chemical industry across Pharma, Biotech and CRO companies. Prior to this, he was a lead the department of computational chemistry at Evotec and medicinal chemist at Eli Lilly. He has contributed to over 40 peer reviewed publications and patents, is an Honorary Lecturer at University of Aberdeen and has been an invited lecturer at the University of Oxford.
Mike completed a BSc(Hons) in both organic chemistry and biochemistry before studying a postgraduate MSc in synthetic chemistry, and later a PhD in computational and medicinal chemistry working in the design and synthesis of kinase inhibitors for the treatment of neurodegenerative diseases. He is a Fellow of the Royal Society for Chemistry and the Royal Statistical Society, and a Chartered Chemist of the Royal Australian Chemical Institute, and a member of the American Chemical Society.